Browse > Article
http://dx.doi.org/10.5012/bkcs.2006.27.9.1335

Low Molecular Weight Polyethylenimine-Mitochondrial Leader Peptide Conjugate for DNA Delivery to Mitochondria  

Choi, Joon-Sig (Department of Biochemistry, College of Natural Sciences, Chungnam National University)
Choi, Min-Ji (Department of Bioengineering, College of Engineering, Hanyang University)
Go, Gyeong-Su (Department of Internal Medicine, Mitochondrial Research Group, College of Medicine, Inje University)
Rhee, Byoung-Doo (Department of Internal Medicine, Mitochondrial Research Group, College of Medicine, Inje University)
KimPak, Young-Mi (Asan Institute for Life Science, University of Ulsan)
Bang, In-Seok (MyGene Bioscience Institute)
Lee, Min-Hyung (Department of Bioengineering, College of Engineering, Hanyang University)
Publication Information
Abstract
It has been found that a number of diseases are associated with mutations in the mitochondrial DNA. Therapeutic gene delivery to mitochondria has been suggested as a clinical option for these diseases. In this study, we developed a gene carrier to mitochondria by the conjugation of mitochondrial leader peptide (LP) to polyethylenimine (PEI). Mitochondrial LP conjugated PEI (PEI-LP) was synthesized with low molecular weight PEI (2,000 Da, PEI2K). Gel retardation assay showed that PEI2K-LP formed complexes at a 1.0/1 weight ratio. In addition, PEI2K-LP protected DNA from the enzymatic degradation for at least 60 min, while naked DNA was completely degraded within 20 min. PEI2K-LP was compared with LP conjugated high molecular weight PEI (25,000 Da, PEI25K) in terms of toxicity and delivery efficiency. MTT assay showed that PEI2K-LP had much lower cytotoxicity than PEI25K-LP to 293 cells. In addition, cell-free DNA delivery assay showed that PEI2K-LP delivered more DNA to mitochondria at a 1.8/1 weight ratio than naked DNA or PEI. This result suggests that PEI2K-LP may be useful for the development of mitochondrial gene therapy system with lower cytotoxicity.
Keywords
Gene delivery; Mitochondria; Leader peptide; Polyethylenimine;
Citations & Related Records

Times Cited By Web Of Science : 6  (Related Records In Web of Science)
Times Cited By SCOPUS : 3
연도 인용수 순위
1 Rabilloud, T.; Kieffer, S.; Procaccio, V.; Louwagie, M.; Courchesne, P. L.; Patterson, S. D.; Martinez, P.; Garin, J.; Lunardi, J. Electrophoresis 1998, 19, 1006   DOI   ScienceOn
2 Lopez, M. F.; Kristal, B. S.; Chernokalskaya, E.; Lazarev, A.; Shestopalov, A. I.; Bogdanova, A.; Robinson, M. Electrophoresis 2000, 21, 3427   DOI   ScienceOn
3 Kim, T.; Seo, H. J.; Baek, J.; Park, J. H.; Park, J. S. Bull. Korean Chem. Soc. 2005, 26, 175   DOI
4 Holt, I. J.; Harding, A. E.; Cooper, J. M.; Schapira, A. H.; Toscano, A.; Clark, J. B.; Morgan-Hughes, J. A. Ann. Neurol. 1989, 26, 699   DOI   ScienceOn
5 Fischer, D.; Bieber, T.; Li, Y.; Elsasser, H. P.; Kissel, T. Pharm. Res. 1999, 16, 1273   DOI   ScienceOn
6 Ballinger, S. W.; Shoffner, J. M.; Gebhart, S.; Koontz, D. A.; Wallace, D. C. Nat. Genet. 1994, 7, 458   DOI   ScienceOn
7 Ballinger, S. W.; Shoffner, J. M.; Hedaya, E. V.; Trounce, I.; Polak, M. A.; Koontz, D. A.; Wallace, D. C. Nat. Genet. 1992, 1, 11   DOI
8 Kumar, A.; Agarwal, S.; Heyman, J. A.; Matson, S.; Heidtman, M.; Piccirillo, S.; Umansky, L.; Drawid, A.; Jansen, R.; Liu, Y.; Cheung, K. H.; Miller, P.; Gerstein, M.; Roeder, G. S.; Snyder, M., Genes Dev. 2002, 16, 707   DOI   ScienceOn
9 Wallace, D. C. Gene 2005, 354, 169   DOI   ScienceOn
10 Shoffner, J. M.; Wallace, D. C. Heart Dis. Stroke 1992, 1, 235
11 Pulkes, T.; Hanna, M. G. Adv. Drug Deliv. Rev. 2001, 49, 27   DOI   ScienceOn
12 Wallace, D. C.; Shoffner, J. M.; Trounce, I.; Brown, M. D.; Ballinger, S. W.; Corral-Debrinski, M.; Horton, T.; Jun, A. S.; Lott, M. T. Biochim. Biophys. Acta 1995, 1271, 141   DOI   ScienceOn
13 Wallace, D. C.; Lott, M. T.; Shoffner, J. M.; Brown, M. D. J. Inherit. Metab. Dis. 1992, 15, 472   DOI
14 Holt, I. J.; Harding, A. E.; Petty, R. K.; Morgan-Hughes, J. A. Am. J. Hum. Genet. 1990, 46, 428
15 D'Souza, G. G.; Boddapati, S. V.; Weissig, V. Mitochondrion 2005, 5, 352   DOI   ScienceOn
16 D'Souza, G. G.; Rammohan, R.; Cheng, S. M.; Torchilin, V. P.; Weissig, V. J. Control. Release 2003, 92, 189   DOI   ScienceOn
17 Weissig, V.; Torchilin, V. P. Adv. Drug Deliv. Rev. 2001, 49, 127   DOI   ScienceOn
18 Weissig, V.; D'Souza, G. G.; Torchilin, V. P. J. Control. Release 2001, 75, 401   DOI   ScienceOn
19 Han, S.; Mahato, R. I.; Sung, Y. K.; Kim, S. W. Mol. Ther. 2000, 2, 302   DOI   ScienceOn
20 Lee, M.; Kim, S. W. Pharm. News 2002, 9, 407
21 Seibel, P.; Trappe, J.; Villani, G.; Klopstock, T.; Papa, S.; Reichmann, H. Nucleic Acids Res. 1995, 23, 10   DOI   ScienceOn
22 Koh, J. J.; Ko, K. S.; Lee, M.; Han, S.; Park, J. S.; Kim, S. W. Gene Ther. 2000, 7, 2099   DOI
23 Choi, J. S.; Lee, M. Bull. Korean Chem. Soc. 2005, 26, 1209   DOI   ScienceOn
24 Lee, M.; Kim, S. W. Pharm. Res. 2005, 22, 1   DOI
25 Chan, C. K.; Jans, D. A. Hum. Gene Ther. 1999, 10, 1695   DOI   ScienceOn
26 Brown, M. D.; Hosseini, S.; Steiner, I.; Wallace, D. C.; Korn- Lubetzki, I. Mov. Disord. 2004, 19, 235   DOI   ScienceOn
27 Cartier, R.; Reszka, R. Gene Ther. 2002, 9, 157   DOI   ScienceOn
28 Lee, M.; Rentz, J.; Han, S. O.; Bull, D. A.; Kim, S. W. Gene Ther. 2003, 10, 585   DOI   ScienceOn
29 Lee, M.; Choi, J. S.; Choi, M. J.; Pak, Y. K.; Rhee, B. D.; Ko, K. S. J. Drug Target 2006, in press
30 Lee, M.; Han, S. O.; Ko, K. S.; Koh, J. J.; Park, J. S.; Yoon, J. W.; Kim, S. W. Mol. Ther. 2001, 4, 339   DOI   ScienceOn
31 Barry, M. E.; Pinto-Gonzalez, D.; Orson, F. M.; McKenzie, G. J.; Petry, G. R.; Barry, M. A. Hum. Gene Ther. 1999, 10, 2461   DOI   ScienceOn
32 Kang, H. C.; Lee, M.; Bae, Y. H. Crit. Rev. Eukaryot. Gene Expr. 2005, 15, 317   DOI   ScienceOn
33 Godbey, W. T.; Wu, K. K.; Mikos, A. G. J. Biomed. Mater. Res. 1999, 45, 268   DOI   ScienceOn
34 Andersson, S. G.; Zomorodipour, A.; Andersson, J. O.; Sicheritz-Ponten, T.; Alsmark, U. C.; Podowski, R. M.; Naslund, A. K.; Eriksson, A. S.; Winkler, H. H.; Kurland, C. G. Nature 1998, 396, 133   DOI   ScienceOn